Vanguard Group Inc Kodiak Sciences Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KOD
# of Institutions
111Shares Held
43MCall Options Held
87.8KPut Options Held
7.3K-
Baker Bros. Advisors LP New York, NY17.3MShares$38.1 Million1.15% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$8.49 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.72MShares$3.79 Million0.03% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.61MShares$3.55 Million0.24% of portfolio
-
Silverarc Capital Management, LLC1.24MShares$2.73 Million2.19% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $114M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...